Newsletter

Last Week in Healthcare Reform: April 4th, 2022

Stakeholders continue to urge for full implementation of consumer surprise medical billing protections; a new report seeks to clarify the relationship between PBMs and drug prices; studies link rising costs and low-value to care delivered by hospital-employed physicians; and, a focus on value-based care improves outcomes and reduces costs.

Last Week in Healthcare Reform: March 28th, 2022

Scapegoating PBMs diverts focus away from who’s really to blame for high drug prices; meanwhile, research continues to poke holes in Big Pharma’s innovation rhetoric; a new campaign is launched highlighting the value of employer-provided health coverage; and, patients want hospitals to disclose emergency room fees.

Last Week in Healthcare Reform: March 14th, 2022

A new report dispels the myth that drug rebates increase costs; supporters of surprise medical billing consumer protections react to a recent court decision impacting one of the new law’s key provisions; enrollment in the Medicare Advantage program continues to grow; and, stakeholders point the way forward on integrating care.

Last Week in Healthcare Reform: March 7th, 2022

New research dispels the myth that higher hospital prices automatically translate into better health outcomes; private-equity interests exerting growing influence over our healthcare delivery model; spending on drugs continues its upward trajectory; and, a look at the impact of health-related social needs on overall health.

Last Week in Healthcare Reform: February 28th, 2022

Congressional lawmakers find common cause in their support of Medicare Advantage; stakeholders remind consumers of the important protections now in place against surprise medical billing – even as those protections are challenged in the courts; meanwhile, the cost of an ambulance ride continues to go up; and, a new study highlights provider markups for specialty drugs.

Last Week in Healthcare Reform: February 21st, 2022

Stakeholders highlight how PBMs improve health outcomes and the patient experience; advocates come together to support bipartisan legislation aimed at closing gaps in mental healthcare for Medicare beneficiaries; hospital consolidation draws increased ire; and, lawmakers propose to extend waivers promoting telehealth access.

Last Week in Healthcare Reform: February 14th, 2022

Pharmaceutical manufacturers raise prices on hundreds of drugs; meanwhile, hospital drugs are projected to see price increases of their own; a new study shows the impact of provider market concentration on consumers’ healthcare costs; and, Medicaid continues to play a critical role in the health of America’s children.

Last Week in Healthcare Reform: February 7th, 2022

stakeholders respond to legal challenges to new surprise medical billing consumer protections; meanwhile, emergency room costs continue to overwhelm patients; and, a new report details how rising drug prices are impacting millions of Medicare enrollees.

Last Week in Healthcare Reform: January 31st, 2022

A new analysis links provider concentration with higher insurance costs; regulators target hospital compliance with new consumer surprise medical billing protections; stakeholders urge lawmakers to restore flexibility for telehealth coverage; and, a pair of new reports underscores the impact of rising drug prices.